Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ANI PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 32,782 shares of ANIP (ANI PHARMACEUTICALS INC), worth $2.5M as of 2026-Q1. The position was increased (+6.2% shares). ANIP represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$2.5M
Current Shares
32,782
Total Value Change
-$215,458
Total Shares Change
-10,189
Other major holders of ANIP: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.
Increased |
| 32,782 |
+6.2% |
| $2.5M |
| 0.0% |
| $76.10 |
28 |
| 2025-Q4 | Increased | 30,867 | +4.0% | $2.4M | 0.0% | $79.42 | 27 |
| 2025-Q3 | Decreased | 29,666 | -46.7% | $2.7M | 0.0% | $91.93 | 0 |
| 2025-Q2 | Increased | 55,624 | +15.1% | $3.6M | 0.0% | $65.50 | 30 |
| 2025-Q1 | Increased | 48,322 | +0.9% | $3.2M | 0.0% | $67.61 | 27 |
| 2024-Q4 | Increased | 47,899 | +41.1% | $2.6M | 0.0% | $54.21 | 35 |
| 2024-Q3 | Decreased | 33,951 | -21.0% | $2M | 0.0% | $58.78 | 0 |
| 2024-Q2 | Increased | 42,971 | +176.6% | $2.7M | 0.0% | $63.68 | 42 |